Current and Emerging Novel Approaches to the Management of Patients with CLL/SLL and MCL - 2023 PCE Oncology Spring Conferences – Hematologic Malignancies

Share

Program Content

Activities

  • Managing CLL/SLL and MCL
    Current and Emerging Novel Approaches to the Management of Patients with CLL/SLL and MCL
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 25, 2023

    View Activity
  • Managing CLL/SLL and MCL with BTKis
    Current and Novel Approaches to the Management of Patients With CLL/SLL and MCL Using BTK Inhibitors
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 25, 2023

    View Activity
  • BTKi and BCL-2i in MCL and CLL/SLL
    Mastering the Use of BTK- and BCL2- Inhibitors in the Management of MCL and CLL/SLL
    BriefCase
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 27, 2023

    Expires: June 26, 2024

    View Activity

Faculty

cover img faculity

Beth Faiman, PhD, MSN, APRN-BC, AOCN, BMTCN, FAAN, FAPO

Cleveland Clinic Taussig Cancer Institute
Department of Hematology and Medical Oncology
Member, Population and Cancer Prevention Program
Case Comprehensive Cancer Center
Cleveland, Ohio

Provided by

ProCE Banner

Provided by Partners for Advancing Clinical Education (PACE)

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca